Development Of Pretomanids And Their Therapeutic Uses In The Treatment Of Tuberculosis. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, p. 2307–2313, 2022. DOI: 10.47750/pnr.2022.13.S05.362. Disponível em: https://pnrjournal.com/index.php/home/article/view/4023.. Acesso em: 28 jun. 2026.